Alexion Jumps After Blood Disorder Drug Succeeds In Head-To-Head Trial
March 15, 2018 at 09:36 AM EDT
Shares of Alexion jumped in pre-market trading after the company said its rare blood disorder drug was successful in a late-stage study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.